Results 101 to 110 of about 1,745 (114)

A head-to-head comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/MR in patients with nasopharyngeal carcinoma: a prospective study

European Journal of Nuclear Medicine and Molecular Imaging, 2021
QingYao Liu, Yongkang Gai, Kunyu Yang
exaly  

Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET/CT in evaluating the extent of disease in gastric adenocarcinoma

European Journal of Nuclear Medicine and Molecular Imaging, 2021
Ofer Shamni, Ido Wolf, Jonathan Kuten
exaly  

[18F]AlF-NOTA-FAPI-04: FAP-targeting specificity, biodistribution, and PET/CT imaging of various cancers

European Journal of Nuclear Medicine and Molecular Imaging, 2022
Jinming Yu, Xiaohui Luan, Xiaoli Liu
exaly  

[18F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[18F]FDG PET/CT

European Journal of Nuclear Medicine and Molecular Imaging, 2022
Jingsong Mao, Xingyu Mu
exaly  

What radiolabeled FAPI pet can add in breast cancer? A systematic review from literature

Annals of Nuclear Medicine, 2023
Laura Evangelista, Orazio Schillaci, Luca Filippi   +2 more
exaly  

Characterization of the benign lesions with increased 68Ga-FAPI-04 uptake in PET/CT

Annals of Nuclear Medicine, 2021
Weibing Miao, Shaobo Yao, Jieling Zheng
exaly  

Clinical Utility of F-18 Labeled Fibroblast Activation Protein Inhibitor (FAPI) for Primary Staging in Lung Adenocarcinoma: a Prospective Study

Molecular Imaging and Biology, 2021
Xinqing Lin, Chengzhi Zhou, Xinlu Wang
exaly  

Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience

Tomography, 2022
Tülay Kuş, İlkay Doğan, Yusuf Burak ÇAYIRLI   +2 more
exaly  

Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer

European Journal of Nuclear Medicine and Molecular Imaging, 2020
Hua Wu, Yizhen Pang, Long Sun
exaly  

[Ga]/[Y]FAPI-46: Automated production and analytical validation of a theranostic pair

Nuclear Medicine and Biology, 2022
exaly